Hyperdynamic state in chronic liver diseases

Area of Science:

• Cardiovascular Physiology
• Hepatology
• Gastroenterology

Background:

• Chronic portal hypertension is linked to reduced splanchnic arteriolar resistance and increased portal venous outflow.
• This leads to a hyperdynamic splanchnic and systemic circulation (high cardiac index, low systemic vascular resistance).
• The systemic effects precede regional changes, potentially due to delayed vasodilator impact on the splanchnic bed.

Purpose of the Study:

• To investigate the mechanisms underlying the hyperdynamic circulatory state in chronic portal hypertension.
• To identify the vasoactive substances responsible for vasodilation.
• To explore the role of plasma volume expansion in the development of the hyperdynamic state.

Main Methods:

• Review of existing studies on vasoactive substances (glucagon, bile acids, nitric oxide, prostaglandins) in portal hypertension.
• Analysis of findings in animal models (rats) with portal hypertension.
• Examination of the relationship between vasodilation and plasma volume expansion.

Main Results:

• Glucagon and bile acids are potent splanchnic vasodilators in animal studies, but lack systemic effects.
• Nitric oxide and prostaglandins have been proposed but yield mixed results.
• Plasma volume expansion was observed after vasodilation in rats, suggesting a link to the hyperdynamic state.

Conclusions:

• The hyperdynamic circulation in portal hypertension involves both vasodilation and increased venous return.
• Plasma volume expansion appears to be a crucial factor connecting vasodilation to the sustained hyperdynamic state.
• Further research is needed to fully elucidate the specific vasodilators and their systemic impact.